Beta-Lactam Antibiotics Cause Excessive Bleeding, Other ‘Ebola-Like’ Side Effects
It’s just like the pharmaceutical paradigm to get a drug passed through government agencies that causes ‘Ebola-like’ symptoms. This is the case with the latest Beta-Lactam antibiotics being used throughout third world countries.
Beta-Lactam is being heralded as a new discovery. A new class of “Non-β-lactam Inhibitors of Penicillin-Binding Proteins with Gram-Positive Antibacterial Activity” that supposedly work by inhibiting cell wall synthesis by the bacterial organism.
These drugs, like many others from Big Pharma, are highly toxic. One of their side effects is excessive bleeding, which is part of the scare-mongering campaign going on with Ebola right now to distract us all while the U.S. government wages its latest WWIII attempt.
Similarly, adenovirus vaccines, which have been used in Guinea and Liberia (the epicenter of Ebola), have, according to vaccines.gov, the following adverse effects: blood in the urine or stool, diarrhea, headaches, inflammation of the stomach or intestines, and pneumonia.
Another effect of Ebola – skin rashes. But never mind that reporter Charles Yates discovered that pollution from a rubber plantation in Liberia was causing ‘Ebola’ like skin rashes.
Just ask yourself, is this yet another way for our government (sold to Big Pharma) to push more antibiotics and vaccines on people, or more psychological warfare? Sounds like another conspiracy, eh?
As Anthony Gucciardi explained in his article, ‘Bat Flu’ Scare Hits Media Among Weaponized Bird Flu Release Debate, this isn’t the first time a germ epidemic has been pushed into public psyche’s:
“The news could not have come at a better time for some scientists who continue to push for a release of the mutated H5N1 bird flu strain, which was mutated 5 times in order to become highly contagious between ferrets – the very animal model used to study human flu infection.Taking attention away from the bird flu release controversy, bat flu may soon become the new focus in the field of potentially threatening viruses. . .”
Hey little lady, I hear there is some nasty virus going around, want to take a bite of my anti-virus candy? Our government is a big drug pusher, and I’d be wary of any more nonsensical talk of Ebola virus popping up just any old place without looking into it more closely. Some wise people even say the ‘epidemics’ that the U.S. drug pushers keep trying to flog us with are part of a ‘man-made’ project. Maybe it’s true. Stay informed.
“There are some experimental drugs under development by pharma companies that show some promise, but nothing is commercialized yet. One fascinating development worth investigating further is that TEKMIRA Pharmaceuticals, a company working on an anti-Ebola drug, just received a $1.5 million cash infusion from none other than Monsanto. Click here to read the press release, which states ‘Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle (LNP) delivery technology to pharmaceutical partners.’
The money from Monsanto is reportedly related to the company’s developed of RNAi technology used in agriculture. The deal is valued at up to $86.2 million, according to the WSJ. (11) Another press release about Tekmira reveals a $140 million contract with the U.S. military for Ebola treatment drugs:
TKM-Ebola, an anti-Ebola virus RNAi therapeutic, is being developed under a $140 million contract with the U.S. Department of Defense’s Medical Countermeasure Systems BioDefense Therapeutics (MCS-BDTX) Joint Product Management Office.
Additional Tekmira partnership are listed at this Tekmira web page.”
And guess what – there is a possible Ebola/Monsanto connection.
Christina Sarich is a humanitarian and freelance writer helping you to Wake up Your Sleepy Little Head, and See the Big Picture. Her blog is Yoga for the New World. Her latest book is Pharma Sutra: Healing the Body And Mind Through the Art of Yoga.